London Stock Exchange today welcomes MGC Pharmaceuticals ("MGC Pharma" or the "Company") (LSE, ASX: MXC), a Bio-Pharma company with a “Nature to Medicine” strategy at the forefront of the emerging global phytocannabinoid derived medicines looking on the London Main Market Listing. ...